China Cord Blood beats by $0.01, revenue in-line

China Cord Blood (NYSE:CO): FQ1 EPS of $0.06 beats by $0.01.

Revenue of $24.71M (+18.0% Y/Y) in-line.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs